DavidLesliePatersonMD

Clinical Trials

• NCCLS Interpretive Criteria for Salmonella Start of enrollment: 2006 Mar 01

  Completed

• Towards Reducing Resistance and Hematological Toxicity of Linezolid Start of enrollment: 2005 Aug 01

  Completed

• Pharmacodynamic Parameters of Two Different Doses of Cefepime Start of enrollment: 2005 Sep 01

  Completed

• Voriconazole as Prophylaxis for Liver Transplant Recipients Start of enrollment: 2005 Sep 01

  Completed

• Organ Transplant Infection Prevention and Detection Project Start of enrollment: 2006 May 01

  Completed

• Piperacillin as a Part of Antibiotic Streamlining in the Intensive Care Unit Start of enrollment: 2005 Sep 01

  Completed

• Invasive Fungal Infections Surveillance Initiative Start of enrollment: 2005 Aug 01

  Completed

• Gram Negative Bacteremia, Risk Factors for Failure of Therapy Start of enrollment: 2005 Apr 01

  Completed

• Prospective Study of Drug Resistant Pathogens Among Liver, Intestinal and Multivisceral Transplant Recipients Start of enrollment: 2005 Oct 01

  Completed

• WP16302 A Bioequivalence Study Comparing Ganciclovir From the Valganciclovir Syrup Formulation and the Commercial Valganciclovir 450mg Tablet (Valcyte®) at a Dose of 900mg in Kidney Transplant Recipients Start of enrollment: 2006 Feb 01

  Terminated

  Phase 3

• Mechanisms of Resistance and Molecular Epidemiology of Commonly Encountered Multi-Resistant Bacteria Start of enrollment: 2006 Jan 01

  Completed

• Antibiotic Resistant Community-Acquired E. Coli Start of enrollment: 2006 Feb 01

  Completed

• Emergence of Gram-negative Resistance in Blood Culture Isolates of Solid-organ Transplant Recipients Start of enrollment: 2006 Sep 01

  Completed

• Changing Patterns of Candida Infections in Urban Medical Centers Start of enrollment: 2006 Aug 01

  Completed

• Piperacillin/Tazobactam for Bacteremia With Organisms Producing Chromosomally-Encoded AmpC Beta-Lactamase Start of enrollment: 2007 Feb 01

  Completed

• Clinical Impact of Fluoroquinolone Resistance in Bacteremia Caused by Gram-Negative Bacilli of Urinary Tract Origin Start of enrollment: 2007 Feb 01

  Completed

• Comparison of the Quantiferon®-TB GOLD (in Tube) Assay With Tuberculin Skin Testing for Detecting Latent Tuberculosis Infection in Patients With Chronic Liver Disease Being Evaluated for or Awaiting Liver Transplantation Start of enrollment: 2007 Jan 01

  Withdrawn

  Not Applicable

• Quinolone Resistance in Bloodstream Isolates of Escherichia Coli Start of enrollment: 2007 Mar 01

  Completed

• Risk Factors for Carbapenem-resistant Acinetobacter Baumannii Start of enrollment: 2007 Apr 01

  Completed

• Etiology of Community Acquired Pneumonia Start of enrollment: 2007 May 01

  Completed

• Multinational Study of Acinetobacter Bloodstream Infection: Clinical Outcomes and Global Epidemiology-PITT Protocol Start of enrollment: 2009 Apr 01

  Completed

• Clinical Outcomes and Global Epidemiology -Data Coordinating Center Start of enrollment: 2007 Jul 01

  Completed

• Epidemiology of Community - Associated Extended-spectrum Beta-lactamases (ESBL) Producing Escherichia Coli Start of enrollment: 2007 Oct 01

  Completed

• RCT Meropenem vs Piperacillin-Tazobactam for Definitive Treatment of BSI's Due to Ceftriaxone Non-susceptible Escherichia Coli and Klebsiella Spp. Start of enrollment: 2014 Feb 01

  Terminated

  Phase 4

• Trial of Meropenem Versus Piperacillin-Tazobactam on Mortality and Clinial Response Start of enrollment: 2015 Apr 01

  Completed

  Phase 4

• Penicillin Against Flucloxacillin Treatment Evaluation Start of enrollment: 2019 Jul 01

  Withdrawn

  Phase 4

• RCT Cefiderocol vs BAT for Treatment of Gram Negative BSI Start of enrollment: 2019 Oct 28

  Completed

  Phase 2

• Innovative Tool to Limit Spread of COVID 19 in Residential Aged Care Facilities Start of enrollment: 2020 May 06

  Terminated

  Not Applicable

• Join now to see all